Atlas Trials

Recurrent Head and Neck Cancer

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Head and Neck Cancer

RecordFirmDate
BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) (NCT04969861)Nektar Therapeutics2022-03-09
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers (NCT04902027)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2021-07-01
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (NCT04260126)PDS Biotechnology Corp.2021-03-29
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 (NCT04534205)BioNTech SE2021-01-07
Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer (NCT03937141)Chinook Therapeutics, Inc. (formerly Aduro)2019-08-26
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer (NCT03754933)GeoVax, Inc.2019-02-11
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer (NCT02842125)MultiVir, Inc.2018-11-20
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03691714)Trisha Wise-Draper2018-10-23
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck (NCT02289209)Dan Zandberg2016-03-09
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer (NCT02567383)Shin Kong Wu Ho-Su Memorial Hospital2015-09-01
Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer (NCT02422979)Rakuten Medical, Inc.2015-06-01
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) (NCT02358031)Merck Sharp & Dohme LLC2015-03-19
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer. (NCT01606566)PCI Biotech AS2012-04-01
A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes (NCT01620242)UNICANCER2012-04-01
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer (NCT00088907)National Cancer Institute (NCI)2004-08-01

Track Recurrent Head and Neck Cancer automatically

Every clearance here is in the API, with alerts when new ones post.